-
Loading metrics
Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
- Ryo Mukai,
- Hidetaka Matsumoto,
- Hideo Akiyama
![PLOS](/resource/img/logo-plos.png)
x
- Published: December 6, 2021
- https://doi.org/10.1371/journal.pone.0259879